 Provider News MaineSeptember 2023 Provider Newsletter Contents Pharmacy | Anthem Blue Cross and Blue Shield | Commercial | September 1, 2023 Sublocade® update
MEBCBS-CRCM-035542-23 Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Availity, LLC is an independent company providing administrative support services on behalf of the health plan. Notices of material changes/amendments to contract may apply for new or updated reimbursement policies, medical policies, or prior authorization requirements. In this issue, please reference the following articles: - Precertification list change notification effective December 1, 2023
- Specialty pharmacy updates – September 2023
- Clinical Criteria updates for specialty pharmacy
- Reimbursement policy update: Documentation Standards for Episodes of Care — Professional
We ask that you review your online provider directory information on a regular basis to ensure it is correct. Access your information by visiting anthem.com/provider, then under Provider Overview, choose Find Care. The Consolidated Appropriations Act (CAA) of 2021 contains a provision that requires online provider directory information be reviewed and updated as needed at least every 90 days. By reviewing your information regularly, you help us ensure your online provider directory information is current. Submit updates and corrections to your directory information by following the instructions on our Provider Maintenance webpage. We will send you an email acknowledging receipt of your request. Online update options include: - Add/change an address location.
- Name change.
- Provider leaving a group or a single location.
- Phone/fax number changes.
- Closing a practice location.
MULTI-BCBS-CM-034855-23-CPN34821 As part of our ongoing quality improvement efforts, we want you to know that some review requests may require documentation to substantiate the attestations that support the clinical appropriateness of the request. This documentation can be uploaded during the intake process. When requested, providers must submit such documentation from the patient’s medical record. If medical necessity is not supported through documents submitted, the request may be denied as not medically necessary. Such documentation is limited to what has been asserted via the prior authorization (PA) review attestations. If the request would be denied as not medically necessary, providers can participate in a PA discussion with an Carelon Medical Benefits Management physician reviewer. * Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. MULTI-BCBS-CM-034178-23-CPN34175 The American Cancer Society (ACS) recommends annual fecal immunochemical test (FIT) kit testing for all adults aged 45 and older with average risk for colon cancer. For these patients, the FIT kit is a convenient, cost-effective, and discreet testing option.1, 2 FIT kits offer a cost-effective, highly accurate option for colorectal cancer screening Screening with FIT kits is convenient and easier than ever. Adopting FIT screening into your practice can help increase patient adherence to colon cancer screening recommendations. Annual FIT improves screening rates and has also been shown to save lives.3 Anthem Blue Cross and Blue Shield network physicians and their patients have access to high-quality, low-cost colorectal cancer screening FIT kits through our National Lab partners Labcorp and Quest Diagnostics.* If you have specific questions, please contact the labs directly: To find Labcorp, Quest Diagnostics, and other participating labs in your patient’s plan network, select Find Care from the Provider Resources menu at anthem.com. References: 1. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.CA Cancer J Clin.2018;68(4):250-281. 2. Occult blood, fecal, immunoassay. Laboratory Corporation of America Holdings and Lexi-Comp Inc. 2021. Accessed April 11, 2022. https://bit.ly/3pRHPlV. 3. Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(12):1645-1658.
* Quest Diagnostics is an independent company providing preventive care technology and health risk assessments services on behalf of the health plan. MULTI-BCBS-CM-024720-23-CPN24527, MULTI-BCBS-CM-034185-23 During the COVID-19 public health emergency, Medicaid and Children’s Health Insurance Program (CHIP) members were able to stay enrolled in their current health coverage regardless of changes in eligibility or status. As Medicaid renewals begin again, your Medicaid and CHIP patients may have to take additional steps, which could include finding a new health plan. Patients who are receiving specialized care for medical conditions such as but not limited to pregnancy, chemotherapy, radiation therapy, or behavioral health therapy, may have additional concerns. They could be in the middle of treatment, scheduled for treatment, or on maintenance medications — and may be worried that they might lose access to their current care provider if they change health plans. The need for continuity of care in this changing landscapeWe’re committed to ensuring a smooth transition for your Medicaid and CHIP patients who are changing health plans. Our Continuity of Care/Transition of Care management team coordinates with you and your patients to ensure access to ongoing care. This includes a personalized evaluation of the member’s condition and network benefits to coordinate and minimize disruption of ongoing care: - Your patients can contact the number on the back of their member ID card and ask about our Transition of Care form. Once filled out, one of our dedicated nurse care managers will contact them to review their specialized care needs within 15 business days.
- Download our provider manual to learn more about our Continuity of Care/Transition of Care Program. Refer to the table of contents and find Continuity of Care/Transition of Care Program under the Quality Improvement Program section.
A proactive approach to prior authorizationsFor patients with CarelonRx, Inc.* as their pharmacy benefit manager and who are on maintenance medications or other medications for treatment, their existing, approved prior authorizations will automatically transfer to their new Anthem Blue Cross and Blue Shield (Anthem) individual and family health plan, and there will be a one-time prior authorization applied for nonformulary medications. This will allow your patients to continue to fill their current medications and allow additional time to initiate the prior authorization process for any formulary differences. You and your patients can count on us for supportYour patients who are receiving specialized care may have concerns about continuing their care and staying with their current care providers. We want you to feel confident you have resources and answers to guide them. Together, we can ease your patients’ potential concerns and ensure a smooth transition for those who choose an Anthem individual and family health plan. If you would like more information, contact your Provider Relationship Management representative, or call the number on the back of the patient’s ID card. * CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan. MULTI-BCBS-CM-026689-23-CPN26000 Effective for all claims received on and after October 1, 2023, Anthem Blue Cross and Blue Shield (Anthem) is updating its outpatient facility editing system to align with correct coding guidelines. For claims received on or after October 1, 2023, when revenue codes 0278, 0636, 0760, 0761, 0762, and 0769 are billed with an inappropriate HCPCS or CPT® code, they will be denied. For assistance with coding guidelines, please refer to CPT coding guidelines and Encoder Pro. If you believe you have received a denial in error, please follow the standard claim dispute process for Anthem. Digital Request for Additional Information (Digital RFAI) is the fastest and easiest way to get us the documents we need to process your claim. Now, it is even better! We’ve added filter, sort, and search features for greater productivity. New filtering functions are ideal for organizations where more than one person is responsible for submitting claim attachments. Another great feature: your filters are saved (locked) – so you can see your desired filter view each time you log on but easily clear them when your search criteria changes.

We are committed to shared success and reporting is just another way we are giving Digital RFAI users a productivity boost. We’ve added reporting fields that can be used for both History and Inbox reports. Fields available for History and Inbox reports
Expanded reporting fields are downloadable! Use the download option to meet your specific reporting requirements. 
We’re here to help! Want to know more about receiving digital notifications for faster claims processing? Visit the Digital RFAI learning microsite or reach out to your Provider Relations Account Manager. MULTI-BCBS-CM-035616-23-CPN35217 Description/Approach Provider performance can vary widely in relation to efficiency and quality. Our goal as your Medicare health plan partner is to ensure our members receive high-quality care that leads to improved member health outcomes across a wide range of variables. We will add a new sorting option on the Find Care tool for members to leverage when they are searching for a non-PCP specialist provider. This sorting option, called Personalized Match Phase 1, is based on each provider’s score relative to their peers in the patient’s preferred mileage search radius. Providers will be listed in order of their total score, though no individual scores will appear within the tool or be visible to the covered patients. The Personalized Match Phase 1 algorithm will be based on quality and efficiency criteria to assist members in making more informed choices about their medical care. Other sorting options will still be available on Find Care for our members. Members should consider a variety of factors when making decisions for choosing a specialist provider to manage their care. We evaluate provider groups and individual providers annually, using updated quality and efficiency methodologies and data. Continue reading the rest of this article * Optum is an independent company providing assessment and reporting services on behalf of the health plan. MEAMH-CR-032270-23-CPN32264 ATTACHMENTS (available on web): Personalized Match Phase 1: Specialist Provider Overview (pdf - 0.68mb) We understand that providing the information needed to process a claim can cause payment delays, and the manual methods associated with mailing letters and returning information non-digitally is costly and inefficient. We’re changing that by implementing a new process: Digital Request for Additional Information (Digital RFAI), and we’re inviting you to participate. Digital requests for additional information are 50% faster than returning documentation any other way — making it the most efficient way to receive and return information — resulting in faster claim payments. Participation in Digital RFAI is easy- Registration:
- Your organization’s Availity* administrator will register for Medical Attachments:
- This enables you to receive digital notices (instead of paper) and to attach the requested documents directly to your claim.
- Ensure all of your billing NPIs/TINs are registered.
- User roles:
- Your Availity administrator will also update or add new users with these specific role assignments through Availity Essentials:
- Claims Status
- Medical Attachments
- This enables the users to view the Availity Attachment Dashboard.
- Ready to go:
- After the registration and user roles are completed on Availity, the Digital RFAI process is ready to go.
- Requests will automatically appear on the Attachments Dashboard each morning (when documents are needed).
Additional supportYou, your organization’s Availity administrator, or other members of your team may need additional support – and we’re to help: - For Availity Administrators: Take this training to ensure your NPIs are registered properly.
- For those sending attachments: Take this user training to learn about accessing notifications, sorting and filtering, and other enhancements that improve your experience.
Through our efforts, we are committed to reducing administrative burden and ensuring timely payments because we value you, our care provider partner. For additional resources, visit the Digital RFAI webpage or contact your Provider Relations Account Manager. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. MULTI-BCBS-CM-036134-23-CPN35203 AMH Health, LLC is transitioning to the Availity Essentials* Authorization application. You may already be familiar with the Availity multi-payer Authorization app because thousands of providers are already using it for submitting prior authorizations for other payers. AMH Health is eager to make it available to our providers, too. In September, you can begin using the same authorization app you use for other payers for AMH Health. Interactive care reviewer (ICR) is still availableIf you need to refer to an authorization that was submitted through ICR, you will still have access to that information. We’ve developed a pathway to access your ICR dashboard. You will simply follow the prompts provided through the Availity Authorization app. To make it even more convenient, you can pin your authorizations from the ICR application to your Availity Authorization app dashboard. Innovation in processWhile we grow the Availity Authorization app to provide you with AMH Health -specific information, you will still need to access ICR for: - Appeals.
- Behavioral health authorizations and inquiries.
- Federal Employee Program® authorizations and inquiries.
- HealthLink authorizations and inquiries.
- Medical specialty prescription authorizations and inquiries.
Notices in the Availity Authorization app will guide you through the process for accessing ICR for alternate authorization and appeals functions. Training is availableIf you aren’t already familiar with the Availity Authorization app, training is available. Visit the training site to enroll for an upcoming live webcast or to access an on-demand recording at the Availity Authorization training site. Now, give it a tryAccessing the Availity Authorization app is easy. Ask your organization’s Availity administrator to ensure you have the Authorization role assignment. Without the role assignment, you will not be able to access the Authorization application. Then, just log onto Availity.com to access the app through the Patient Registration tab by selecting Authorizations and Referrals. MEAMH-CR-030955-23-CPN29378 Starting mid-September, search for patient information in Availity Essentials* Eligibility and Benefits without having a member ID. We’ve updated and streamlined the process to eliminate the need for the member ID while maintaining the highest HIPAA standards. Easily search for patient eligibility and benefits details using the Patient Search option of patient last name, patient first name, date of birth, and patient zip code. Find Eligibility and Benefits Inquiry on Availity’s top menu bar under Patient Registration. Once it becomes available, make sure to use the new search feature when you need to find member information and do not have access to the member ID. Need the member ID for another capability in Availity Essentials? When you use the new search option in Eligibility and Benefits Inquiry and see the eligibility and benefits details, the member’s current ID details will be available and allow you to transact within other digital capabilities where the member ID is required. Watch for more information on the Availity Essentials home page under News and Announcements to notify you when this feature is available. Get access to Availity Essentials nowIf you and your organization aren’t currently registered for Availity Essentials, now is the time to make that happen. Availity Essentials offers secure online access for working together and is free to our providers. To register, visit the availity.com Registration Information page. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan. MULTI-BCBS-CM-025687-23-CPN25562 Register today for the youth mental health forum hosted by AMH Health, LLC and Motivo* for AMH Health providers on September 27, 2023. Wednesday, September 27, 2023 3:30 to 5 p.m. Eastern time This important event will address the critical need to engage young people in leading their mental health. By deepening the discussion on youth mental health, we can do our part to foster a culture of understanding and support for youth and young adults. Authentic conversations lead to reducing implicit bias and improving the health and wellbeing of all Americans and the communities in which we live and serve. Please join us to hear from a diverse panel of experienced professionals and young leaders as we explore the challenges experienced by today’s youth, amplify the experiences and ideas of young people, and equip attendees with practical tools and innovative approaches to create meaningful change. Each forum will continue the exploration of ways we can reduce disparities in healthcare, demonstrate cultural humility, address, and deconstruct bias, have difficult and productive conversations, learn about valuable resources, increase inclusion, advance equity in healthcare. Please register for this event by visiting this link. * Motivo is an independent company providing a virtual forum on behalf of the health plan. MEAMH-CR-029401-23-CPN29379 Register today for the youth mental health forum hosted by Anthem Blue Cross and Blue Shield (Anthem) and Motivo* for Anthem providers on September 27, 2023. Wednesday, September 27, 2023 3:30 to 5 p.m. Eastern time This important event will address the critical need to engage young people in leading their mental health. By deepening the discussion on youth mental health, we can do our part to foster a culture of understanding and support for youth and young adults. Authentic conversations lead to reducing implicit bias and improving the health and wellbeing of all Americans and the communities in which we live and serve. Please join us to hear from a diverse panel of experienced professionals and young leaders as we explore the challenges experienced by today’s youth, amplify the experiences and ideas of young people, and equip attendees with practical tools and innovative approaches to create meaningful change. Each forum will continue the exploration of ways we can reduce disparities in healthcare, demonstrate cultural humility, address, and deconstruct bias, have difficult and productive conversations, learn about valuable resources, increase inclusion, advance equity in healthcare. Please register for this event by visiting this link. * Motivo is an independent company providing a virtual forum on behalf of the health plan. MULTI-BCBS-CRCM-029408-23-CPN29379 On December 22, 2022, May 2, 2023, and May 19, 2023, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for AMH Health, LLC. These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. If you have questions or need additional information, use this email. Please see the explanation/definition for each category of Clinical Criteria below: - New: Newly published criteria
- Revised: Addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
Please share this notice with other providers in your practice and office staff. Please note: - The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by AMH Health only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | September 11, 2023 | *CC-0237 | Qalsody (tofersen) | New | September 11, 2023 | *CC-0238 | Hydroxyprogesterone caproate | New | September 11, 2023 | *CC-0240 | Zynyz (retifanlimab-dlwr) | New | September 11, 2023 | CC-0165 | Trodelvy (sacituzumab govitecan) | Revised | September 11, 2023 | CC-0002 | Colony Stimulating Factor Agents | Revised | September 11, 2023 | CC-0128 | Tecentriq (atezolizumab) | Revised | September 11, 2023 | CC-0098 | Doxorubicin Liposome (Doxil, Lipodox) | Revised | September 11, 2023 | CC-0101 | Torisel (temsirolimus) | Revised | September 11, 2023 | CC-0107 | Bevacizumab for Non-Ophthalmologic Indications | Revised | September 11, 2023 | CC-0143 | Polivy (polatuzumab vedotin-piiq) | Revised | September 11, 2023 | CC-0092 | Adcetris (brentuximab vedotin) | Revised | September 11, 2023 | CC-0095 | Velcade (bortezomib) | Revised | September 11, 2023 | CC-0105 | Vectibix (panitumumab) | Revised | September 11, 2023 | CC-0178 | Synribo (omacetaxine mepesuccinate) | Revised | September 11, 2023 | CC-0114 | Jevtana (cabazitaxel) | Revised | September 11, 2023 | CC-0145 | Libtayo (cemiplimab-rwlc) | Revised | September 11, 2023 | *CC-0032 | Botulinum Toxin | Revised | September 11, 2023 | CC-0068 | Growth Hormone | Revised | September 11, 2023 | *CC-0057 | Krystexxa (pegloticase) | Revised | September 11, 2023 | *CC-0125 | Opdivo (nivolumab) | Revised | September 11, 2023 | *CC-0225 | Tzield (teplizumab-mzwv) | Revised | September 11, 2023 | *CC-0124 | Keytruda (pembrolizumab) | Revised |
Plans offered by AMH Health, LLC., a joint venture between MaineHealth and Anthem Partnership Holding Company, LLC. AMH Health is an independent licensee of the Blue Cross Blue Shield Association. MEAMH-CR-031951-23-CPN30755 Effective December 1, 2023, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by AMH Health, LLC for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | 64581 | Incision for implantation of neurostimulator electrode array; sacral nerve (transforaminal placement) | 64628 | Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; first 2 vertebral bodies, lumbar or sacral | C1764 | Event recorder, cardiac (implantable) | E0466 | Home ventilator, any type, used with non-invasive interface, (for example, mask, chest shell) | E0766 | Electrical stimulation device used for cancer treatment, includes all accessories, any type | L5845 | Knee-Shin Sys Stance Flexion | L5910 | Endo Below Knee Alignable Sy |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com.* Providers may also call the number on the back of the member’s ID card for assistance with PA requirements. * Availity, LLC is an independent company providing administrative support services on behalf of the health plan.
UM AROW# 4489 MEAMH-CR-028203-23-CPN27653 Prior Authorization | Anthem Blue Cross and Blue Shield | Commercial | September 1, 2023 Notice of material change/amendment to contract Precertification list change notification effective December 1, 2023The following services will be added to precertification for the effective dates listed below. To obtain precertification, providers can access Availity Essentials* (Availity.com) or call Anthem Blue Cross and Blue Shield’s Utilization Management department using the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved. Precertification can help avoid unnecessary charges or penalties by helping to ensure that the member's care is medically necessary and administered at an appropriate network facility and by a network provider. Add to precertification | Criteria | Criteria description | Code | Effective date | CG-SURG-27 | Gender Affirming Surgery | 15769 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 53410 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 53420 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 53425 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 53430 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 54400 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 57426 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 58150 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 58571 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 58572 | 12/01/2023 | CG-SURG-27 | Gender Affirming Surgery | 58573 | 12/01/2023 | CG-SURG-09 | Temporomandibular Disorders | D7899 | 12/01/2023 | CG-SURG-09 | Temporomandibular Disorders | D9950 | 12/01/2023 | CG-SURG-09 | Temporomandibular Disorders | D9951 | 12/01/2023 | CG-SURG-09 | Temporomandibular Disorders | D9952 | 12/01/2023 | CG-DME-06 | Compression Devices for Lymphedema | E0656 | 12/01/2023 | CG-DME-06 | Compression Devices for Lymphedema | E0657 | 12/01/2023 | CG-DME-45 | Ultrasound Bone Growth Stimulation | E0760 | 12/01/2023 | CG-DME-06 | Compression Devices for Lymphedema | K1024 | 12/01/2023 | CG-DME-06 | Compression Devices for Lymphedema | K1025 | 12/01/2023 |
* Availity, LLC is an independent company providing administrative support services on behalf of the health plan. UM AROW #4605 MEBCBS-CM-034403-23-SRS33553 ATTACHMENTS (available on web): CG-DME-45.pdf (pdf - 0.3mb) CG-DME-06.pdf (pdf - 0.34mb) CG-SURG-09.pdf (pdf - 0.34mb) CG-SURG-27.pdf (pdf - 0.65mb) Effective for dates of service on and after December 1, 2023, the following codes will require prior authorization through Carelon Medical Benefits Management, Inc.* (formerly AIM Specialty Health®). CPT® code | Description | 0042T | Cerebral Perfusion Analysis Using Computed Tomography with Contrast Administration, Including Post-Processing of Parametric Maps with Determination of Cerebral Blood Flow, Cerebral Blood Volume, and Mean Transit Time |
As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon in one of several ways: - Access Carelon’s ProviderPortalSM directly at www.providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
- Access Carelon via the Availity Essentials* website at www.availity.com.
Note: This update does not apply to the Federal Employee Program®. If you have any questions related to guidelines, please contact Carelon via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. * Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Availity, LLC is an independent company providing administrative support services on behalf of the health plan. MEAMH-CR-025223-23-CPN25171 Reimbursement Policies | Anthem Blue Cross and Blue Shield | Commercial | September 1, 2023 Notice of material change/amendment to contract Reimbursement policy update: Documentation Standards for Episodes of Care — ProfessionalBeginning with dates of service on or after December 1, 2023, Anthem Blue Cross and Blue Shield will expand the current Documentation Standards for Episodes of Care — Professional reimbursement policy to apply to facility providers. This policy outlines how and what elements must be documented for an episode of care. The policy will be retitled Documentation Standards for Episodes of Care — Professional and Facility. For specific policy details, visit the reimbursement policy page at Anthem.com. Effective as of June 14, 2023, Anthem Blue Cross and Blue Shield updated the Documentation and Reporting Guidelines for Evaluation and Management (E/M) Services reimbursement policy to include the 2021 American Medical Association (AMA) CPT® Level of Medical Decision Making (MDM) table to align with the 2021-2023 Centers for Medicare & Medicaid Services (CMS) and AMA-CPT code changes. This table will be listed under the policy section titled Selecting a Level of Medical Decision Making for Coding an E/M Service. When determining the level of E/M service using MDM, this table will be used instead of the 1995/1997 CMS risk tables and the Marshfield Clinic tables. Additional updates to this reimbursement policy are as follows: - Documentation submitted in accordance with this reimbursement policy will remain subject to signature and other requirements as stated in the related Documentation for Episodes of Care reimbursement policy. Therefore, the policy was updated to include the following note: All documents are subject to the Documentation Requirements for Episodes of Care policy.
- The Related Coding section was expanded to include “other” E/M services, as defined in the policy.
For specific policy details, visit the corresponding reimbursement policy page from the list below: Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare. Effective June 14, 2023, Anthem Blue Cross and Blue Shield’s split care surgical modifier language was removed from the Global Surgical Package — Professional reimbursement policy and added to a new standalone reimbursement policy titled Split Care Surgical Modifiers — Professional. This policy allows reimbursement based on a percentage of the fee schedule or contracted/negotiated rate for the surgical procedure. The percentage is determined by the modifier that is appended to the procedure code. The Related Coding section of the policy identifies the applicable modifiers and standard reimbursement percentages. For specific policy details, visit the reimbursement policy page at anthem.com. Pharmacy | Anthem Blue Cross and Blue Shield | Commercial | September 1, 2023 Notice of material change/amendment to contract Specialty pharmacy updates – September 2023Specialty pharmacy updates for Anthem Blue Cross and Blue Shield (Anthem) are listed below. Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by the Anthem's Medical Specialty Drug Review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc.*, a separate company. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. Including the National Drug Code (NDC) code on your claim may help expedite claim processing of drugs billed with a not otherwise classified (NOC) code. Prior authorization updatesEffective for dates of service on and after December 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process. Access our Clinical Criteria to view the complete information for these site of prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0241 | Elfabrio (pegunigalsidase alfa-iwxj) | J3490, J3590 | CC-0242* | Epkinly (epcoritamab-bysp) | C9399, J3490, J3590, J9999 | CC-0243 | Vyjuvek (beremagene geperpavec) | J3490, J3590 | CC-0062 | Yuflyma (adalimumab-aaty) | J3490, J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Quantity limit updatesEffective for dates of service on and after December 1, 2023, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT® Code(s) | CC-0241 | Elfabrio (pegunigalsidase alfa-iwxj) | J3490, J3590 | CC-0228 | Leqembi (lecanemab) | J0174 | CC-0243 | Vyjuvek (beremagene geperpavec) | J3490, J3590 | CC-0062 | Yuflyma (adalimumab-aaty) | J3490, J3590 |
Pharmacy | Anthem Blue Cross and Blue Shield | Commercial | September 1, 2023 Notice of material change/amendment to contract Clinical Criteria updates for specialty pharmacyThe following Clinical Criteria documents were endorsed at the June 12, 2023, Clinical Criteria meeting. Visit our website to access the Clinical Criteria information. New Clinical Criteria effective December 1, 2023The following Clinical Criteria are new: • CC-0241 Elfabrio (pegunigalsidase alfa-iwxj)* • CC-0242 Epkinly (epcoritamab-bysp)* • CC-0243 Vyjuvek (beremagene geperpavec)* Revised Clinical Criteria effective December 1, 2023The following Clinical Criteria were revised and might result in services that were previously covered but may now be found to be not medically necessary: • CC-0015 Infertility and HCG Agents* • CC-0061 Gonadotropin Releasing Hormone Analogs for the Treatment of Non-Oncologic Indications* • CC-0062 Tumor Necrosis Factor Antagonists* • CC-0177 Zilretta (triamcinolone acetonide extended-release)* * The applicable policy is attached to this article in PDF format. Effective April 5, 2023, Sublocade® can no longer be filled at Accredo Specialty Pharmacy.* Members currently filling through Accredo Specialty Pharmacy will need to switch to CVS Specialty Pharmacy.* A member of the CVS Specialty Pharmacy Care team will be contacting prescribers to obtain a new prescription. Prescribers can contact CVS Specialty Pharmacy at 877-254-0015. * Accredo Specialty Pharmacy is an independent company providing pharmacy services on behalf of the health plan. CVS is an independent company providing pharmacy services on behalf of the health plan. MULTI-BCBS-CM-034784-23-CPN34761 The following Part B medications from the current Clinical Criteria Guidelines are included in our medical step therapy precertification review process. Step therapy review will apply upon precertification initiation, in addition to the current medical necessity review (as is current procedure). Step therapy will not apply for members who are actively receiving medications listed below. There are no clinical changes to Clinical Criteria CC-005, Hyaluronan Injections. Based on feedback, the table listing the preferred and non-preferred products has been updated to present the information in a more useful manner. The updated table identifies preferred alternatives based on injection series. Clinical Criteria Guidelines are publicly available on the provider website. Visit the Clinical Criteria page to search for specific criteria. Clinical UM Guidelines | Preferred drug(s) | Nonpreferred drug(s) | CC-0005 | Single injection: Durolane Three injection series: Euflexxa Gel-Syn Five injection series: Supartz | Single injection: Gel-One Monovisc Synvisc-one Two injection series: Hymovis Three Injection series: Orthovisc Synojoynt Synvisc Triluron Trivisc Five injection series: Genvisc 850 Hyalgan Visco-3 |
MEAMH-CR-031134-23-CPN30365 **This collateral ran originally in the July 1, 2023, newsletter and was also posted on the provider portal with an October 1, 2023, effective date. The new date of service will begin on November 1, 2023.** Effective for dates of service on and after November 1, 2023, the specialty Medicare Part B drug listed in the table below will be included in our precertification review process. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims. HCPCS or CPT® codes | Medicare Part B drugs | J1931 | Aldurazyme (laronidase) | J0256 | Aralast NP (alpha-1 proteinase inhibitor), Prolastin-C (alpha-1 proteinase inhibitor), Zemaira (alpha-1 proteinase inhibitor) | J1786 | Cerezyme (imiglucerase) | J0584 | Crysvita (burosumab-twza) | J1743 | Elaprase (idursulfase) | J3060 | Elelyso (taliglucerase) | J0180 | Fabrazyme (agalsidase beta) | J0257 | Glassia (alpha-1 proteinase inhibitor) | J0638 | Ilaris (canakinumab) | J0221 | Lumizyme (alglucosidase alfa) | J3397 | Mepsevii (vestronidase alfa) | J1458 | Naglazyme (galsulfase) | J0219 | Nexviazyme (avalglucosidase alfa-ngpt) | J0222 | Onpattro (patisiran) | J1322 | Vimizim (elosulfase alfa) | J3385 | Vpriv (velaglucerase) | J0775 | Xiaflex (collagenase clostridium histolyticum) |
MEAMH-CR-032242-23-CPN31947 AMH Health, LLC reimburses providers for Medicare Advantage medication reconciliation. Please see the FAQ to learn how to receive reimbursement for post inpatient discharge medication reconciliation. |